1.0
4 Nov 2019
Recommend
CEO approval
Business outlook
Pros
Great potential for the only drug they have.
Cons
The drug is still in clinical trials. They are so disorganized it will probably never get approved. Small company with too much infighting among leadership. Leadership does not know what it's doing and rarely follows through with any of their directives.